Ranolazine Toxicity Secondary to Paxlovid

An Emergency Use Authorization (EUA) was issued by the FDA on December 22, 2021 for the investigational antiviral drug nirmatrelvir copackaged with the HIV-1 protease inhibitor ritonavir (Paxlovid - Pfizer) for outpatient treatment of mild to moderate COVID-19 in children 12 years and old that are h...

Descripción completa

Detalles Bibliográficos
Autores principales: Casey, Bradley, Vernick, Robert C, Bahekar, Amol, Patel, Divyang, Ncogo Alene, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161677/
https://www.ncbi.nlm.nih.gov/pubmed/37153311
http://dx.doi.org/10.7759/cureus.37153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161677/
https://www.ncbi.nlm.nih.gov/pubmed/37153311
http://dx.doi.org/10.7759/cureus.37153

Ejemplares similares